Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-05-02

Clinical Trial Update: Renal Denervation for Treatment of Resistant Hypertension in Patients With Chronic Kidney Disease

View source ↗

Summary

The clinical trial investigating renal denervation for resistant hypertension in patients with chronic kidney disease is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Renal denervation device

Snippet

Sponsor: Singapore General Hospital | Conditions: Hypertension, Chronic Kidney Disease | Status: NO_LONGER_AVAILABLE